Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,444 | 5,272 | 6,393 | 6,566 | 7,809 |
| Receivables | 3,530 | 4,842 | 5,687 | 5,483 | 4,388 |
| Inventories | 9,870 | 10,904 | 11,273 | 11,433 | 13,824 |
| TOTAL | $19,428 | $22,094 | $25,005 | $24,863 | $27,782 |
| Non-Current Assets | |||||
| PPE Net | 3,658 | 4,263 | 4,846 | 5,525 | 6,049 |
| Intangibles | 2,926 | 2,926 | 2,926 | 2,926 | 2,926 |
| Other Non-Current Assets | 1,229 | 1,358 | 1,576 | 1,787 | 1,988 |
| TOTAL | $7,813 | $8,547 | $9,348 | $10,238 | $10,963 |
| Total Assets | $27,241 | $30,641 | $34,353 | $35,101 | $38,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,042 | 13,275 | 2,800 | 2,265 | 2,800 |
| Accounts payable and accrued liabilities | 3,001 | 5,491 | 4,915 | 6,065 | 7,178 |
| Accrued Expenses | 8,153 | 7,662 | 7,589 | 7,518 | 7,613 |
| Other current liabilities | 1,437 | 2,616 | 3,780 | 1,363 | N/A |
| TOTAL | $30,859 | $31,176 | $21,427 | $19,663 | $19,782 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 150 | 11,207 | 11,782 | 11,307 |
| Deferred Revenues | 2,226 | 2,132 | 2,343 | 2,452 | 2,191 |
| Other Non-Current Liabilities | 1,043 | 1,255 | 1,227 | 1,444 | 1,536 |
| TOTAL | $1,263 | $1,591 | $12,657 | $13,482 | $13,079 |
| Total Liabilities | $32,122 | $32,767 | $34,084 | $33,145 | $32,861 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,597 | 36,597 | 33,395 | 32,523 | 2,297 |
| Common Shares | 36 | 33 | 33 | 3 | 2 |
| Retained earnings | -327,511 | -326,083 | -323,285 | -316,800 | -311,474 |
| Other shareholders' equity | -184 | 1,544 | 1,564 | 1,650 | 4,833 |
| TOTAL | $-4,881 | $-2,126 | $269 | $1,956 | $5,884 |
| Total Liabilities And Equity | $27,241 | $30,641 | $34,353 | $35,101 | $38,745 |